Clinical Trial

Theories of Working Memory and Consolidation/RECOnsolidation in the Process of Resorption of Post-traumatic Symptoms.

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 26, 2025 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
EMDR is a psychotherapeutic approach recommended by the World Health Organization (WHO) for the treatment of disorders such as post-traumatic stress disorder, anxiety, depression and, more generally, psychological distress. In all these disorders, intrusions are one of the symptoms leading to intense emotional distress. EMDR therapy, by making intrusions less emotional and less present in the mind (i.e. less vivid), would reduce psychological distress. This symptomatological reduction would be made possible by the therapist's application of alternating bilateral visual (rapid eye movements following a point from left to right), auditory (tones emitted alternately in the right ear and then in the left ear) and/or tactile (tapping with fingers on the left and right shoulders alternately) stimulations administered while the patient concentrates on his or her intrusive thoughts. Accordingly, the aim of this research is to investigate the efficacy of self-administration of Alternating Bilateral Stimulations (ABS), on the emotional intensity (emotionality) associated with negative intrusive thoughts (or intrusions).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-06-19.
Status change: Not Yet Recruiting → Recruiting 2025-11-20
Trial Details
NCT Number NCT06469333
Lead Sponsor University of Lorraine
Conditions Working Memory, Consolidation/Recconsolidation Memory, Eye Movement Desensitization and Reprocessing, Alterning Bilateral Stimulation, Stress Disorders, Post-Traumatic, Intrusive Memories, Vividness, Emotivity
Enrollment 150 participants
Start Date 2024-09-06
Primary Completion 2026-06 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2025-11-26